Latest Health News

Page 14 of 271
Nexsen has paused its StrepSure clinical programme after an interim review identified performance improvements needed before a US FDA submission, pushing the target timetable back by roughly one quarter. Its shares were then suspended pending an announcement about a potentially material contract for an additional device.
Ada Torres
Ada Torres
24 Sept 2026
4DMedical delivered sharp growth in scans, sites and operating revenue as CT:VQ moved into commercial deployment across several global markets. But the company remains loss-making and its auditor issued a qualified opinion over the carrying value of goodwill and other intangible assets.
Victor Sage
Victor Sage
24 Sept 2026
Elixinol Wellness will acquire personalised supplement platform Vitable for headline consideration of A$2.5 million in shares, adding recurring revenue and more than 7,850 active subscribers. The deal could lift combined revenue to A$27 million by 2028, but remains subject to shareholder approval and carries meaningful dilution risk.
Victor Sage
Victor Sage
24 Sept 2026
BCAL Diagnostics has begun introducing ClearNote Health’s Avantect Multi-Cancer blood test in Australia, starting with Sydney and Melbourne. The test reported 56.2% sensitivity and 98.4% specificity in a case-control validation study, but the company says a negative result does not rule out cancer.
Ada Torres
Ada Torres
23 Sept 2026
PainChek grew recurring revenue, implemented licences and customer sites in FY2026, but its $8.94 million loss and $9.24 million operating cash outflow prompted an explicit going-concern warning from its auditor. The company is now betting that US deployments and a sharper commercial focus can convert market access into cash-generating growth.
Victor Sage
Victor Sage
23 Sept 2026
HITIQ has secured a $1.5 million R&D tax incentive loan facility and drawn half the available funding, providing immediate liquidity while adding interest-bearing debt. The arrangement with a related party also puts shareholder approval of proposed security in focus.
Victor Sage
Victor Sage
23 Sept 2026
Biome Australia Limited (ASX:BIO) delivered its second consecutive profitable year in FY26, with revenue rising 30% to $23.9 million and operating cash flow turning positive. But the headline $3.6 million profit includes a $2.4 million deferred tax benefit, leaving FY27 execution as the real test of the company’s growth plan.
Ada Torres
Ada Torres
22 Sept 2026
OzAurum Resources has shifted Mulgabbie North from feasibility work into early construction, backed by encouraging laboratory heap leach results and a $4.10 million placement. But the company remains loss-making, cash-burning and dependent on further funding, with its auditor flagging a material uncertainty over going concern.
Maxwell Dee
Maxwell Dee
21 Sept 2026
Vectus Biosystems swung to a $1.56 million FY2026 profit, but the result was driven largely by the sale of its VB4-P5 compound for XORTX shares and warrants rather than recurring operations. The company is now directing its resources towards VB0004 while its auditor flags material uncertainty over ongoing funding.
Ada Torres
Ada Torres
18 Sept 2026
Memphasys has signed a three-year exclusive distribution agreement covering the Czech Republic, Slovakia and Kazakhstan, with minimum purchases worth approximately A$674,000. The deal expands Felix’s European footprint while adding dedicated commercial leadership in the region.
Victor Sage
Victor Sage
18 Sept 2026
Resonance Health has signed a 24-month alliance with London-based Image Analysis Group, making its quantitative MRI endpoints orderable across IAG’s global clinical-trial network. The opportunity is potentially significant, but remains uncontracted: two pilot studies come first, with no minimum revenue or volume commitments.
Victor Sage
Victor Sage
17 Sept 2026
Thrive Tribe Technologies is developing WooBoard CARE, a free-to-use directory intended to help Australian veterans find allied health providers accepting DVA Veteran Cards and taking new clients. The initial build targets physiotherapy and psychology across the Gold Coast, Brisbane and Ipswich, with providers potentially paying subscriptions for verified listings.
Sophie Babbage
Sophie Babbage
17 Sept 2026

Browse the archive

Full archive